Neuromodulation最新文献_第4页

6. Externally powered SCS at C2 for refractory neuropathic occipital and facial pain 6. 外部供电SCS在C2治疗难治性神经性枕部和面部疼痛

IF 3.2 3区医学

Neuromodulation Pub Date : 2025-06-01 DOI: 10.1016/j.neurom.2025.03.008

M. Macdonald, H. Bedran, E. Pereira, M. Tavakkoli

引用次数: 0

38. Patient experience of closed loop multi-waveform spinal cord stimulation 38. 闭环多波形脊髓刺激的患者体验

IF 3.2 3区医学

Neuromodulation Pub Date : 2025-06-01 DOI: 10.1016/j.neurom.2025.03.040

A. Gulve, V. Goodridge, S. Copley

引用次数: 0

40. Peripheral nerve stimulation using fast acting subperception therapy for nummular headache 40. 快效亚知觉疗法治疗麻木性头痛的外周神经刺激

IF 3.2 3区医学

Neuromodulation Pub Date : 2025-06-01 DOI: 10.1016/j.neurom.2025.03.042

D.R. Anwar, S.C. Balasubramanian, G. Vajramani

引用次数: 0

12. Closed loop low dose spinal cord stimulation for the treatment of upper extremity neuropathic pain 12. 闭合回路低剂量脊髓刺激治疗上肢神经性疼痛

IF 3.2 3区医学

Neuromodulation Pub Date : 2025-06-01 DOI: 10.1016/j.neurom.2025.03.014

Dr A. Gulve, V. Goodridge, S. Copley

引用次数: 0

17. Differential target multiplexed spinal cord stimulation: a UK cost-effectiveness analysis 17. 差异目标多路脊髓刺激：英国成本效益分析

IF 3.2 3区医学

Neuromodulation Pub Date : 2025-06-01 DOI: 10.1016/j.neurom.2025.03.019

A. Gulve , V. Mehta , D.A. Provenzano , S. Eggington , S. Scheffler , N.C. Gasquet , C.N. Ricker

引用次数: 0

18. Dopamine modulates subthalamic nucleus laser-evoked potentials in Parkinson’s disease 18. 多巴胺调节帕金森病丘脑下核激光诱发电位

IF 3.2 3区医学

Neuromodulation Pub Date : 2025-06-01 DOI: 10.1016/j.neurom.2025.03.020

R.S. Shah , A.M. Nair , B. Ishihara , M.G. Hart , L. Ricciardi , F. Morgante , E.A.C. Pereira

引用次数: 0

8. Case report of intrathecal drug delivery system implantation for cancer pain 8. 鞘内给药系统植入治疗癌性疼痛1例报告

IF 3.2 3区医学

Neuromodulation Pub Date : 2025-06-01 DOI: 10.1016/j.neurom.2025.03.010

S.M. McLeod, A.M. Vitali, K. Waterhouse

引用次数: 0

Information for Readers 读者资讯

IF 3.2 3区医学

Neuromodulation Pub Date : 2025-06-01 DOI: 10.1016/S1094-7159(25)00173-4

引用次数: 0

Evaluation of a Miniature, Injectable, Wireless Stimulator to Treat Obstructive Sleep Apnea 一种微型、可注射、无线刺激器治疗阻塞性睡眠呼吸暂停的评估。

IF 3.2 3区医学

Neuromodulation Pub Date : 2025-06-01 DOI: 10.1016/j.neurom.2024.11.009

Andrew J. Fuglevand PhD , E. Fiona Bailey PhD , Tarek Makansi PhD

{"title":"Evaluation of a Miniature, Injectable, Wireless Stimulator to Treat Obstructive Sleep Apnea","authors":"Andrew J. Fuglevand PhD , E. Fiona Bailey PhD , Tarek Makansi PhD","doi":"10.1016/j.neurom.2024.11.009","DOIUrl":"10.1016/j.neurom.2024.11.009","url":null,"abstract":"<div><h3>Introduction</h3><div>Moderate-to-severe obstructive sleep apnea (OSA) affects a large segment of the US population and is characterized by repetitive and reversible obstruction of the upper airway during sleep. Untreated OSA is associated with increased incidence of heart attack, stroke, and motor vehicle accidents due to sleepiness. Continuous positive airway pressure is often prescribed, but most patients with OSA are nonadherent. One effective alternative is stimulation of the hypoglossal nerve (HGN) that acts to open and stiffen the airway. However, currently available HGN stimulators require major surgery to implant a pacemaker-like device and leads that connect to a cuff electrode encircling the HGN. In this study, we performed preliminary tests in rats and humans of a miniature stimulating device that, in the future, could be injected near the HGN with ultrasound guidance.</div></div><div><h3>Methods and Results</h3><div>This device (1 × 9 mm) is activated wirelessly using a small wearable (3.5-cm diameter) that would be placed on the skin under the jaw in human patients. The system was effective in robustly activating the rat sciatic nerve at distances up to 2.5 cm from the wearable. Furthermore, the device delivered through injection could fully activate the rat sciatic nerve if placed at distances <4 mm from the nerve. The extent of migration of the device measured in seven rats over a one-month period was not significant for most injectables, but six of 18 did change position (mainly along the injection path). We discuss strategies for minimizing migration in the future. Lastly, we report on tests in one awake human subject, wherein wireless stimulation of the HGN caused >60% increase in airflow during inspiration.</div></div><div><h3>Conclusion</h3><div>Collectively, these initial experiments encourage future studies to determine the utility of this system in alleviating OSA in human subjects.</div></div>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":"28 4","pages":"Pages 580-591"},"PeriodicalIF":3.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142896257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Tracking and Failure Analysis of Explanted Neuromodulation Devices 外植神经调节装置的跟踪与失效分析。

IF 3.2 3区医学

Neuromodulation Pub Date : 2025-06-01 DOI: 10.1016/j.neurom.2024.11.008

Institute of Neuromodulation Device Disposition Committee, Tess L. Veuthey MD, PhD , Deborah Duricka PhD , Dario J. Englot MD, PhD , David A. Provenzano MD , David M. Dickerson MD , Sanket Dhruva MD , Christopher Miranda Loftus MD, Dr.h.c. (Hon.) , Nina Meizu-Nwaba PharmD, MPH, MSc , David Prescott McMullen MD , Richard B. North MD , Pierre D’Haese PhD , Peter E. Konrad MD, PhD , Lawrence Poree MD, MPH, PhD

引用次数: 0